ECU
WST icon

Eisler Capital (US)’s West Pharmaceutical WST Stock Holding History

Eisler Capital (US)’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,210
Closed -$3.36M – 683
2024
Q2 		$3.36M Buy
+10,210
New +$3.61M 0.06% 261

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Eisler Capital (US)'s WST Position: Q3 2024 in Review

Eisler Capital (US) sold out of West Pharmaceutical (WST) in Q3 2024, closing a stake of 10,210 shares — an estimated $3.36M sold.

Eisler Capital (US) first reported a position in WST in Q2 2024 and held it in 1 quarter. The position peaked at $3.36M in Q2 2024. 730 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • Eisler Capital (US) reported no remaining West Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • Eisler Capital (US) sold 10,210 West Pharmaceutical shares in Q3 2024, an estimated $3.36M.
  • Eisler Capital (US) first reported a position in West Pharmaceutical in Q2 2024 and held it in 1 quarter.
  • Eisler Capital (US)'s West Pharmaceutical position peaked at $3.36M in Q2 2024.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on Eisler Capital (US)'s 13F filing for Q3 2024, filed 14 Nov 2024.